Charles Schwab Investment Advisory’s CVS Health CVS Stock Holding History

Charles Schwab Investment Advisory’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,237,676	Closed	-$315M	–	75
2019 Q4	$315M	Buy	4,237,676 +123,984	+3%	+$8.71M	0.45%	66
2019 Q3	$259M	Buy	4,113,692 +208,145	+5%	+$12.3M	0.4%	80
2019 Q2	$213M	Buy	3,905,547 +506,038	+15%	+$27.3M	0.34%	86
2019 Q1	$183M	Buy	3,399,509 +353,597	+12%	+$21.8M	0.31%	90
2018 Q4	$200M	Buy	3,045,912 +19,165	+0.6%	+$1.43M	0.38%	84
2018 Q3	$238M	Buy	3,026,747 +63,248	+2%	+$4.52M	0.41%	74
2018 Q2	$191M	Buy	+2,963,499	New	+$195M	0.35%	84

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab Investment Advisory's CVS Position: Q1 2020 in Review

Charles Schwab Investment Advisory sold out of CVS Health (CVS) in Q1 2020, closing a stake of 4,237,676 shares — an estimated $315M sold.

Charles Schwab Investment Advisory first reported a position in CVS in Q2 2018 and held it in 7 quarters. The position peaked at $315M in Q4 2019. 1,818 funds tracked by Wall St. Rank hold CVS as of Q1 2020.

Charles Schwab Investment Advisory reported no remaining CVS Health position as of Q1 2020 after selling out during the quarter.
Charles Schwab Investment Advisory sold 4,237,676 CVS Health shares in Q1 2020, an estimated $315M.
Charles Schwab Investment Advisory first reported a position in CVS Health in Q2 2018 and held it in 7 quarters.
Charles Schwab Investment Advisory's CVS Health position peaked at $315M in Q4 2019.
1,818 funds tracked by Wall St. Rank held CVS Health as of Q1 2020.

Based on Charles Schwab Investment Advisory's 13F filing for Q1 2020, filed 15 May 2020.